At 16:00 ET (21:00 GMT), the S&P 500 index... Private payrolls, factory orders, services activity: 3 things to watch By Investing.com - Oct 03, 2023 1 Investing.com -- Stocks sank on Tuesday as ...
Factory orders increased 1.7% after a revised 0.6% decline in December, the Commerce Department's Census Bureau said on Wednesday. Economists polled by Reuters had forecast factory orders ...
BACKGROUND Bacillus Calmette-Guérin (BCG) is one of the most successful vaccines in the world and evidence suggests it can be used as a bacterial vector to deliver heterologous antigens. OBJECTIVES We ...
Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...
On February 4, Merck released financial results for Q4 2024, which, as in previous quarters, once again beat analysts' expectations. This was driven by a strong performance by its oncology ...
Merck said its “once-in-a-lifetime” drug Keytruda could be subject to price reductions under the Inflation Reduction Act, which would lead to a … ...
Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...
Merck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting negotiations next year under the Inflation Reduction Act. In a filing with ...
MANILA, Philippines — Malacañang on Sunday dismissed the latest tirades hurled by former President Rodrigo Duterte that President Ferdinand Marcos Jr. is “veering toward dictatorship ...
The authorization was granted to ImmunityBio, the manufacturer of Anktiva ® (nogapendekin alfa inbakicept-pmln), an interleukin-15 receptor agonist, indicated with BCG for adult patients with BCG ...
Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...
After scrapping plans to build a $2.6 billion battery energy storage system factory in Georgia, FREYR Battery (NYSE: FREY) has rebranded itself as T1 Energy (NYSE: TE). FREYR turned T1 Energy also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback